As physicians and families know too well, though Alzheimer’s disease has been intensely studied for decades, too much is still not known about molecular processes in the brain that cause it. Now researchers at the University of Massachusetts Amherst say new insights from analytic theory and molecular simulation techniques offer a better understanding of amyloid fibril growth and brain pathology.
- Patients of Asian and black backgrounds more likely to die from COVID, large study reveals
- Magnetic waves explain mystery of Sun’s outer layer
- CT identifies patients with high-risk nonalcoholic fatty liver disease (NAFLD)
- Research shows preference for male children is declining in Bangladesh
- Microbiome Search Engine 2 helps researchers explore microbiome space